Alexandria Real Estate Equities
ARE
#2319
Rank
A$11.83 B
Marketcap
A$68.47
Share price
-2.38%
Change (1 day)
-55.84%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Alexandria Real Estate Equities (ARE) - Total debt

Total debt on the balance sheet as of September 2025 : A$21.01 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's total debt is A$21.01 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Alexandria Real Estate Equities - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$20.50 B19.39%
2023-12-31A$17.17 B10.58%
2022-12-31A$15.52 B22.01%
2021-12-31A$12.72 B23.73%
2020-12-31A$10.28 B2.16%
2019-12-31A$10.06 B29.47%
2018-12-31A$7.77 B27.41%
2017-12-31A$6.10 B5.65%
2016-12-31A$5.77 B6.93%
2015-12-31A$5.40 B20.19%
2014-12-31A$4.49 B30.98%
2013-12-31A$3.43 B12.08%
2012-12-31A$3.06 B12.96%
2011-12-31A$2.71 B6.55%
2010-12-31A$2.54 B-16.8%
2009-12-31A$3.05 B-26.57%
2008-12-31A$4.16 B30.6%
2007-12-31A$3.18 B24.14%
2006-12-31A$2.56 B33.61%
2005-12-31A$1.92 B25.34%
2004-12-31A$1.53 B60.8%
2003-12-31A$0.95 B-12.6%
2002-12-31A$1.09 B-2.82%
2001-12-31A$1.12 B45.6%
2000-12-31A$0.77 B44.61%
1999-12-31A$0.53 B5.42%
1998-12-31A$0.50 B365.58%
1997-12-31A$0.10 B-23.74%
1996-12-31A$0.14 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
A$91.60 B 336.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$37.54 B 78.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$63.99 B 204.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.87 B-81.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.84 B 265.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$82.18 B 291.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.96 B-90.62%๐Ÿ‡บ๐Ÿ‡ธ USA